Found: 21
Select item for more details and to access through your institution.
VASOPRESSIN RESPONSE TO HAEMORRHAGE IN RATS: EFFECT OF HYPOXIA AND WATER RESTRICTION.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1991, v. 18, n. 10, p. 725, doi. 10.1111/j.1440-1681.1991.tb01387.x
- By:
- Publication type:
- Article
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 913, doi. 10.3390/jcm8070913
- By:
- Publication type:
- Article
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 913, doi. 10.3390/jcm8070913
- By:
- Publication type:
- Article
Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Administration of Lispro Insulin with Meals Improves Glycemic Control, Increases Circulating Leptin, and Suppresses Ghrelin, Compared with Regular/NPH Insulin in Female Patients with Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 2, p. 485, doi. 10.1210/jc.2005-1338
- By:
- Publication type:
- Article
Use of systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans.
- Published in:
- Frontiers in Pharmacology, 2014, v. 5, p. 1, doi. 10.3389/fphar.2014.00274
- By:
- Publication type:
- Article
Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications.
- Published in:
- Diabetes, 2007, v. 56, n. 11, p. 2790, doi. 10.2337/db07-0784
- By:
- Publication type:
- Article
A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.
- Published in:
- Nutrition & Metabolism, 2012, v. 9, n. 1, p. 68, doi. 10.1186/1743-7075-9-68
- By:
- Publication type:
- Article
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 2, p. 163, doi. 10.1007/s12325-011-0098-x
- By:
- Publication type:
- Article
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exploring the Potential of the SGLT2 Inhibitor Dapaglif lozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 412, doi. 10.2337/dc13-2955
- By:
- Publication type:
- Article
Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 10, p. 3169, doi. 10.2337/dc13-0387
- By:
- Publication type:
- Article
Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: Relationships with Metabolic Outcomes.
- Published in:
- Obesity (19307381), 2013, v. 21, n. 12, p. 2471, doi. 10.1002/oby.20437
- By:
- Publication type:
- Article
Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats.
- Published in:
- Diabetes, 2010, v. 59, n. 10, p. 2653, doi. 10.2337/db09-1564
- By:
- Publication type:
- Article